SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Corixa [CRXA] - cancer vaccines -- Ignore unavailable to you. Want to Upgrade?


To: Larry Liebman who wrote (3)5/18/1998 2:07:00 PM
From: Andreas Helke  Respond to of 222
 
After reading the annual report I had hoped that I would be able to buy some more cheap Corixa shares. Now a well timed press release about their Her2/neu cancer vaccine phase I trial results has screwed up my buying plans. That may be just as well because I am too heavily margined anyway. The news are at go2net.newsalert.com

Andreas



To: Larry Liebman who wrote (3)5/18/1998 8:56:00 PM
From: Andreas Helke  Read Replies (1) | Respond to of 222
 
With a rise of 21.4% today Corixa made it to number 7 of the 10 biggest advancers on NASDAQ. This is quite a difference to the slow but steady downward move of Corixa to which I got accustomed.
Targetet Genetics (TGEN) the other biotech on this list took the number 1 spot with a rise of 77.7%.

Andreas